Terms: = Lung cancer AND WFDC2, EDDM4, HE4, WAP5, dJ461P17.6
64 results:
1. Factors influencing blood tumor marker concentrations in the absence of neoplasia.
Trapé J; Fernández-Galán E; Auge JM; Carbonell-Prat M; Filella X; Miró-Cañís S; González-Fernández C;
Tumour Biol; 2024; 46(s1):S35-S63. PubMed ID: 38517826
[TBL] [Abstract] [Full Text] [Related]
2. Relevance of tumor markers for prognosis and predicting therapy response in non-small cell lung cancer patients: A CEPAC-TDM biomarker substudy.
Geiger K; Joerger M; Roessler M; Hettwer K; Ritter C; Simon K; Uhlig S; Holdenrieder S
Tumour Biol; 2024; 46(s1):S191-S206. PubMed ID: 38363625
[TBL] [Abstract] [Full Text] [Related]
3. Diagnostic value of cerebrospinal fluid human epididymis protein 4 for leptomeningeal metastasis in lung adenocarcinoma.
Li X; Chen K; Li J; Tang X; Ruan H; Guan M
Front Immunol; 2024; 15():1339914. PubMed ID: 38304432
[TBL] [Abstract] [Full Text] [Related]
4. Value of human epididymis secretory protein 4 in differentiating malignant from benign pleural effusion: an analysis of two cohorts.
Yang Q; Niu Y; Wen JX; Yang DN; Han YL; Wen XH; Yan L; Huang JH; Chen H; Zheng WQ; Jiang TW; Hu ZD
Ther Adv Respir Dis; 2023; 17():17534666231216566. PubMed ID: 38084849
[TBL] [Abstract] [Full Text] [Related]
5. Comprehensive analysis of the lncRNAs-related immune gene signatures and their correlation with immunotherapy in lung adenocarcinoma.
Yang Z; Zhu J; Yang T; Tang W; Zheng X; Ji S; Ren Z; Lu F
Br J Cancer; 2023 Oct; 129(9):1397-1408. PubMed ID: 37543671
[TBL] [Abstract] [Full Text] [Related]
6. Pre-analytical stability of the CEA, CYFRA 21.1, NSE, CA125 and he4 tumor markers.
Canki E; Schuurbiers MM; Linders TC; Korse CM; van den Heuvel MM; van Herwaarden AE; van Rossum HH
Tumour Biol; 2024; 46(s1):S15-S25. PubMed ID: 37302060
[TBL] [Abstract] [Full Text] [Related]
7. Liquid biopsy-based decision support algorithms for diagnosis and subtyping of lung cancer.
Visser E; Genet SAAM; de Kock RPPA; van den Borne BEEM; Youssef-El Soud M; Belderbos HNA; Stege G; de Saegher MEA; van 't Westeinde SC; Brunsveld L; Broeren MAC; van de Kerkhof D; Deiman BALM; Eduati F; Scharnhorst V
Lung Cancer; 2023 Apr; 178():28-36. PubMed ID: 36773458
[TBL] [Abstract] [Full Text] [Related]
8. Secreted proteins MDK, wfdc2, and CXCL14 as candidate biomarkers for early diagnosis of lung adenocarcinoma.
Li J; Li J; Hao H; Lu F; Wang J; Ma M; Jia B; Zhuo M; Wang J; Chi Y; Zhai X; Wang Y; Wu M; An T; Zhao J; Yang F; Wang Z
BMC Cancer; 2023 Jan; 23(1):110. PubMed ID: 36721112
[TBL] [Abstract] [Full Text] [Related]
9. The investigation of levels of endothelial cell-specific molecule, progranuline, clusterin, and human epididymis protein 4 in the differential diagnosis of malignant pleural effusions.
Demirbas S; Yerlikaya FH; Yosunkaya S; Can U; Celalettin K
Medicine (Baltimore); 2022 Dec; 101(52):e32471. PubMed ID: 36595996
[TBL] [Abstract] [Full Text] [Related]
10. Development of exploratory algorithms to aid in risk of malignancy prediction of indeterminate pulmonary nodules.
Jeanblanc N; Jackson L; Gawel S; Brophy S; Vaidya S; Syed S; Davis GJ; Borgia JA
Clin Chim Acta; 2022 Oct; 535():197-202. PubMed ID: 36087784
[TBL] [Abstract] [Full Text] [Related]
11. New insights into the diagnostic characteristics and clinical application of serum biomarkers for lung cancer, and human epididymis protein 4 as a new biomarker?
Li M; Zhang Y; Jiang L; Li Y; Li G; Zhou J; Yang C; Li X; Qu W; Chen Y; Chen Q; Wang S; Xing J; Huang H
Neoplasma; 2022 May; 69(3):729-740. PubMed ID: 35471981
[TBL] [Abstract] [Full Text] [Related]
12. Human epididymis protein 4 is associated with severity and poor prognosis of connective tissue disease-associated interstitial lung disease with usual interstitial pneumonia pattern.
Meng K; Tian M; Gui X; Xie M; Gao Y; Shi S; Zhao T; Xiao Y; Cai H; Ding J
Int Immunopharmacol; 2022 Jul; 108():108704. PubMed ID: 35413677
[TBL] [Abstract] [Full Text] [Related]
13. Flexible diagnostic measures and new cut-point selection methods under multiple ordered classes.
Feng Y; Tian L
Pharm Stat; 2022 Jan; 21(1):220-240. PubMed ID: 34449107
[TBL] [Abstract] [Full Text] [Related]
14. Elevated Serum Human Epididymis Protein 4 Is Associated With Disease Activity and Systemic Involvements in Primary Sjögren's Syndrome.
Chen J; Sun F; Bao H; Liang L; Zhan M; Yao H; He J; Liu Y
Front Immunol; 2021; 12():670642. PubMed ID: 34248951
[TBL] [Abstract] [Full Text] [Related]
15. Circulating biomarkers for monitoring therapy response and detection of disease progression in lung cancer patients.
de Kock R; Borne BVD; Soud MY; Belderbos H; Stege G; de Saegher M; van Dongen-Schrover C; Genet S; Brunsveld L; Scharnhorst V; Deiman B
Cancer Treat Res Commun; 2021; 28():100410. PubMed ID: 34107412
[TBL] [Abstract] [Full Text] [Related]
16. Diagnostic value of serum human epididymis protein 4 and cancer antigen 125 in the patients with ovarian carcinoma: A protocol for systematic review and meta-analysis.
Dai HY; Hu F; Ding Y
Medicine (Baltimore); 2021 May; 100(21):e25981. PubMed ID: 34032711
[TBL] [Abstract] [Full Text] [Related]
17. Age-stratified and gender-specific reference intervals of six tumor markers panel of lung cancer: A geographic-based multicenter study in China.
Li Y; Li M; Zhang Y; Zhou J; Jiang L; Yang C; Li G; Qu W; Li X; Chen Y; Chen Q; Wang W; Wang S; Liang Xing J; Huang H
J Clin Lab Anal; 2021 Jun; 35(6):e23816. PubMed ID: 33982344
[TBL] [Abstract] [Full Text] [Related]
18. A practical method to screen and identify functioning biomarkers in nasopharyngeal carcinoma.
Liu C; Guo P; Zhou L; Wang Y; Tian S; Ding Y; Wu J; Zhu J; Wang Y
Sci Rep; 2021 Mar; 11(1):7294. PubMed ID: 33790390
[TBL] [Abstract] [Full Text] [Related]
19. Borderline ovarian tumors: French guidelines from the CNGOF. Part 1. Epidemiology, biopathology, imaging and biomarkers.
Huchon C; Bourdel N; Abdel Wahab C; Azaïs H; Bendifallah S; Bolze PA; Brun JL; Canlorbe G; Chauvet P; Chereau E; Courbiere B; De La Motte Rouge T; Devouassoux-Shisheboran M; Eymerit-Morin C; Fauvet R; Gauroy E; Gauthier T; Grynberg M; Koskas M; Larouzee E; Lecointre L; Levêque J; Margueritte F; Mathieu D'argent E; Nyangoh-Timoh K; Ouldamer L; Raad J; Raimond E; Ramanah R; Rolland L; Rousset P; Rousset-Jablonski C; Thomassin-Naggara I; Uzan C; Zilliox M; Daraï E
J Gynecol Obstet Hum Reprod; 2021 Jan; 50(1):101965. PubMed ID: 33160106
[TBL] [Abstract] [Full Text] [Related]
20. Evaluation of serum human epididymis protein 4 in patients with relapsing-remitting multiple sclerosis.
Adamczyk B; Partyka R; Adamczyk-Sowa M; Wierzbicki K; Sowa P; Kokocińska D
Adv Clin Exp Med; 2020 Aug; 29(8):943-948. PubMed ID: 32790249
[TBL] [Abstract] [Full Text] [Related]
[Next]
